Comparison of Ferucarbotran-Enhanced MRI and Triple-Phase MDCT for the Detection of Hepatocellular Carcinoma in Advanced Liver Cirrhosis
Authors:
Open Access
- 1 January 2008
- journal article
- Published by The Korean Society of Radiology in Journal of the Korean Radiological Society
- Vol. 58 (1) , 53-63
Abstract
Jeon YH, et al. J Korean Radiol Soc. 2008 Jan;58(1):53-63. https://doi.org/10.3348/jkrs.2008.58.1.53Keywords
This publication has 29 references indexed in Scilit:
- Focal Hepatic Lesions: Detection and Characterization with Combination Gadolinium- and Superparamagnetic Iron Oxide–enhanced MR ImagingRadiology, 2003
- Ferucarbotran (Resovist): a new clinically approved RES-specific contrast agent for contrast-enhanced MRI of the liver: properties, clinical development, and applicationsEuropean Radiology, 2003
- Hepatocellular Carcinoma: Detection with Triple-Phase Multi–Detector Row Helical CT in Patients with Chronic HepatitisRadiology, 2003
- Detection of Primary Hepatic Malignancy in Liver Transplant Candidates: Prospective Comparison of CT, MR Imaging, US, and PETRadiology, 2003
- Preoperative Depiction of Hepatocellular Carcinoma: Ferumoxides-enhanced MR Imaging versus Triple-Phase Helical CTRadiology, 2003
- Hepatocellular Carcinoma: Detection with Gadolinium- and Ferumoxides-enhanced MR Imaging of the LiverRadiology, 2002
- Multidetector helical CT of the liver for tumor detection and characterizationEuropean Radiology, 2001
- The prediction of risk of recurrence and time to recurrence of hepatocellular carcinoma after orthotopic liver transplantation: A pilot studyHepatology, 1997
- Liver Transplantation for the Treatment of Small Hepatocellular Carcinomas in Patients with CirrhosisNew England Journal of Medicine, 1996
- ROC Methodology in Radiologic ImagingInvestigative Radiology, 1986